Ryan Specialty Quarterly report pursuant to Section 13 or 15(d)

Derivatives (Tables)

6 Months Ended

Jun. 30, 2024

The location and gains (losses) on derivatives are reported on the Consolidated Statements of Income as follows:


		Three Months Ended June 30,						Six Months Ended June 30,
	Income Statement Caption	2024			2023			2024			2023
Change in the fair value of the Deal-Contingent Forward	General and administrative	$	(2,050	)	$	—		$	(4,532	)	$	—
Total impact of derivatives not designated as hedging instruments		$	(2,050	)	$	—		$	(4,532	)	$	—

Interest rate cap premium amortization	Interest expense, net	$	(1,739	)	$	(1,739	)	$	(3,477	)	$	(3,477	)
Amounts reclassified out of other comprehensive income related to the interest rate cap	Interest expense, net		6,507			5,649			13,051			10,064
Total impact of derivatives designated as hedging instruments		$	4,768		$	3,910		$	9,574		$	6,587

The location and fair value of derivatives are reported on the Consolidated Balance Sheets as follows:


	Balance Sheet Caption	June 30, 2024		December 31, 2023
Derivatives not designated as hedging instruments
Deal-Contingent Forward	Accounts payable and accrued liabilities	$	—	$	852
Derivatives designated as hedging instruments
Interest rate cap	Other non-current assets	$	29,549	$	29,667